Navigation Links
Digirad Corporation Board of Directors Appoints R. King Nelson Chairman
Date:1/7/2008

POWAY, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Digirad Corporation (Nasdaq: DRAD), a leading provider of medical diagnostic imaging products and services to physicians' offices, hospitals and imaging centers, today announced that its board of directors has appointed R. King Nelson, a director and member of the audit and governance committees, chairman of the board effective today.

Nelson, 50, has served on Digirad's board of directors since March 2004. He is currently president and chief executive officer of Uptake Medical. From April 2005 to September 2006 he was president and chief executive officer of Kerberos Proximal Solutions, Inc., a developer of medical devices used for the treatment of vascular disease. From May 1999 to December 2003, he was president and chief executive officer of VenPro Corporation, a medical device company that develops implants for venous vascular and cardiovascular medicine. Nelson has more than 18 years of executive-level experience at Baxter Healthcare Corporation, a health care company, including serving as president of Baxter's perfusion services business. He received a Bachelor of Science degree from Texas Tech University and an MBA degree from the University of Miami.

Nelson commented: "I am pleased to have an opportunity to work with Digirad management, especially to further extend the reach of their centers of influence model in the U.S. Based on my experience on both device and services sides of healthcare, management has initiated a unique approach to providing key imaging services, services that address the needs of not only patients but also the physicians who provide those services, and I look forward to seeing this model play an increasing role in Digirad's growth and path to pro
'/>"/>

SOURCE Digirad Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Digirad Corporation to Release Third Quarter, Nine-Month Financial Results on October 25, 2007
2. Digirad Corporation Named to Deloitte Technology Fast 50
3. Digirad Reports 2007 Third-Quarter, Nine-Month Financial Results
4. Digirad Corporation and The Methodist Hospital in Houston Sign Letter of Agreement
5. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
6. Brooke Franchise Corporation Announces Selected July Results
7. MedThink Communications Retained by NanoBio Corporation
8. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
9. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
10. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
11. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)... Trusted life science softwar...ment clients to engage via GSA. , ... Solutions, an emerging software engineering firm...rd of a U.S. General Services Administration (GSA)...ent customers with the ability to conveniently eng...
(Date:8/28/2008)...tion improved even after conventional therapy, stu...y News) -- Working out on a treadmill improves bra...ed a stroke and gone through the usual rehabilitat...two problems these patients have," said study rese...eurology and neurorehabilitation at the University...
(Date:8/28/2008)...MOUNTAIN VIEW, Calif., Aug. 28 /PRNewswire/ -- The...e Year Award is presented to Redsense,Medical in r...blood loss,detecting device. "Redsense detects the...e lives of many patients"., The device consists o...cted to the alarm using fibre optic technology tha...
(Date:8/28/2008)...IRVINE, Calif., Aug. 28 /PRNewswire-FirstCall/ -- ... announced it will present at the Thomas Weisel,Pa... Time on Thursday,September 4, 2008 at the Four S... Chief Executive Officer, Vicente Anido, Jr.,Ph.D...ial and clinical,progress. To access the live audi...
Breaking Medicine News(10 mins):Health News:Federal and State Agencies Have Easier Access to 5AM Solutions' Award-Winning Software Services 2Health News:Treadmill Workouts Help Stroke Survivors 2Health News:Frost & Sullivan Honours Redsense Medical With the 2008 European Hemodialysis Emerging Company of the Year Award 2Health News:Frost & Sullivan Honours Redsense Medical With the 2008 European Hemodialysis Emerging Company of the Year Award 3
...ifferences in normal peoples sleep. Some are light...asleep right away, while others take their time . ...attributed solely to differences in circumstances,...ctors. But now a study led by Hans Van Dongen, ass...
...procedures among most notable increases. Approxima...ormed worldwide in 2006, up 34 percent from 2004, ...ent member survey conducted by the International S... world's leading medical authority on hair loss an...
...ool of Medicine in St. Louis have just given peopl...at smoking interferes with ligament healing. The r...found that cigarette smoking impairs the recruitme...lays healing following ligament repair surgery. ...
...ngham (UAB) have traced the differences and simila...nd that in human RNA , a significant development t...biotic resistance. The new findings have been rep...thored by Dr. Dmitry Vassylyev, Professor of Bioch...
Other Medicine News:Health News:Individual Differences in Sleep Structure are Biologically Determined 2Health News:Hair Restoration Procedures Performed Worldwide Increased 34 Percent in 2006 2Health News:Hair Restoration Procedures Performed Worldwide Increased 34 Percent in 2006 3Health News:Smoking Hampers Healing of the Ligament 2Health News:Scientists Trace New Pathway That may Stem Antibiotic Resistance 2
(Date:8/27/2008)...cognized Pediatric Heart Center at The Children,s ...unity to Complete Range of Care and ...Pediatric Cardiology Team Treats Every Heart Condi...- The Children,s Hospital at,Montefiore (CHAM) is ...ansplantation to the Bronx, following the recent a...
(Date:8/26/2008)...IS, Aug. 26 /- Semafore Pharmaceutica...l Congress on Targeted Therapies,in Cancer in Wash...lti-targeted kinase inhibitors that demonstrate si...es., A novel and proprietary molecular scaffold h...owing for the design of pan-PI3 kinase inhibitors,...
(Date:8/26/2008)... - Coupled with Innovative Manufacturing - Has Pot...emic Preparedness, ROCKVILLE, Md., Aug. 26 /PRNew... announced today favorable results from the second...its pandemic influenza virus-like,particle (VLP) v...ain an,adjuvant, induced robust neutralizing antib...
(Date:8/25/2008)... Patient calls it a ,miracle, LATHAM, N...from the,Image Guided Radiation Therapy program at...d treating cancer patients using RapidArc(TM),radi...YSE: VAR ), an,advancement that delivers a highly...erapy (IMRT) treatment in two minutes or less., R...
Breaking Medicine Technology:Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health 2Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health 3Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health 4Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 3Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 2Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 3Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 4Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 5Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 6Image Guided Radiation Therapy in Latham, NY. Now Fighting Cancer Using Fast and Precise RapidArc(TM) Radiotherapy Technology 2Image Guided Radiation Therapy in Latham, NY. Now Fighting Cancer Using Fast and Precise RapidArc(TM) Radiotherapy Technology 3NOLabs AB Reports Success in Fight Against Bacteria Causing Urinary Tract Infection 1783 1NOLabs AB Reports Success in Fight Against Bacteria Causing Urinary Tract Infection 1783 2Preclinical Study Shows CTIs Brostallicins Cancer Killing Ability Based on Genetic Profiling 1781 1Preclinical Study Shows CTIs Brostallicins Cancer Killing Ability Based on Genetic Profiling 1781 2Preclinical Study Shows CTIs Brostallicins Cancer Killing Ability Based on Genetic Profiling 1781 3Monogram Biosciences to Present at the JMP Securities Seventh Annual Research Conference 4584 1Monogram Biosciences to Present at the JMP Securities Seventh Annual Research Conference 4584 2Neurotechnologija Changes Corporate Name to Neurotechnology 2890 1Neurotechnologija Changes Corporate Name to Neurotechnology 2890 2
...eir Own Household, SWIFTWATER, Pa., March 27, 2007... April issue of The Pediatric Infectious,Disease J...only,known as whooping cough -- found that househo... cases among infants for whom a,source case could ...tance of vaccination of close contacts of infants ...
... in Valortim-Treated Animals, , PRINCETON, N.J. an...Call/ -- Medarex, Inc. , a leading monoclonal,anti...eld,biotechnology company dedicated to the develop...d that Valortim(TM), a fully human,monoclonal anti...vention and treatment of anthrax infection, has be...
Other Medicine Technology:New Study Confirms Role for Pertussis Immunization of Entire Family,in Reducing Infant Pertussis 2New Study Confirms Role for Pertussis Immunization of Entire Family,in Reducing Infant Pertussis 3New Study Confirms Role for Pertussis Immunization of Entire Family,in Reducing Infant Pertussis 4New Study Confirms Role for Pertussis Immunization of Entire Family,in Reducing Infant Pertussis 5New Study Confirms Role for Pertussis Immunization of Entire Family,in Reducing Infant Pertussis 6Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 2Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 3Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 4Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 5Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 6Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 7Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 8
Flexible vinyl with a rigid bite block. Guedel-style with three internal channels. Individually packaged, 48 per case. Latex Free.
Includes one of each size airway. Plastic. Color coded for size. Single use. Non-Sterile.
Our soft guedel airway is clear and has a color coded bite block. Airway has a smooth finish and is Latex Free. Recommended for single use. Non-Sterile.
Rsch color coded Guedel airways offer our best value on oropharyngeal airways. They uniquely combine color coding for size and flexible material without a premium price. Color coded airways are latex
Medicine Products: